StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by SGordonon Aug 11, 2019 11:34am

135 Views

Post# 30015926

RE:RE:T.SZLS - CAP Accredited and CLIA Certified (FDA)

FacBine..... You can show all statements+articles you want/can but, the fact now is we doesn't have nothing concrete (why the SP is at 0,11$...)! So, excepting a huge turnover, you (and the others) can stop believe/waiting in a 30 millions revenu and even a 10-15 millions...!! GLTA

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features